本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 近日，保龄宝生物股份有限公司（以下简称"公司"）收到持股5%以上股东宁波趵朴富通资产管理中心 (有限合伙)（以下简称"趵朴富通"）出具的《关于股份减持触及1%刻度的告知函》，获悉其在2025年7 月3日至2025年8月14日期间通过集中竞价、大宗交易方式合计减持公司股份4,190,000股，本次变动触及 1%刻度。现将具体情况公告如下： 登录新浪财经APP 搜索【信披】查看更多考评等级 股东宁波趵朴富通资产管理中心(有限合伙)保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 保龄宝生物股份有限公司 ■ 2025年8月15日 ...

Investment Rating - The report gives an "Accumulate" rating for the sweetener industry, marking it as a first-time rating [5]. Core Insights - The sweetener market in China is poised for significant growth, with a current per capita sugar consumption of approximately 30g/day, exceeding the recommended limit of 25g/day. This indicates a substantial potential for sugar substitutes [1][9]. - The report highlights the dual demand for health and sweetness, leading to the rise of sugar substitutes. Nearly 40% of American consumers are opting for low-calorie or zero-calorie sugars to reduce calorie intake [1][17]. - The report identifies two main investment themes: the ongoing demand for artificial sweeteners like sucralose and the potential for new natural sweeteners like allulose, driven by consumer acceptance and technological advancements [3]. Market Overview - The sweetener market is characterized by a growing trend towards reduced sugar consumption, with a projected sugar consumption of 15.9 million tons in China for the 2025/26 season, reflecting a compound annual growth rate (CAGR) of about 0.5% from 2015/16 to 2025/26 [9]. - The beverage sector represents the largest share of sugar demand, with a market penetration rate for sugar-free beverages at only 7.9% in 2023, suggesting significant room for growth [20][22]. Selection Criteria - The choice of sweeteners is influenced by economic factors, taste, and safety. Artificial sweeteners generally have a higher sweetness-to-price ratio compared to natural sweeteners, which often have lower ratios [2][28]. - Safety concerns are paramount, with natural sweeteners typically having no Acceptable Daily Intake (ADI) limits, while artificial sweeteners are subject to ADI restrictions and some face safety controversies [2][40]. Product Analysis - Sucralose is identified as the largest artificial sweetener in terms of market space, with a global sales volume of approximately 20,000 tons in 2023, reflecting a 7% year-on-year growth [46]. - Erythritol, a low-calorie sugar alcohol, has seen rapid market expansion, particularly following its use in popular beverages, leading to a significant increase in production capacity [63][65]. Future Outlook - The report emphasizes the importance of consumer education and acceptance for the successful adoption of new sweeteners like allulose, which currently faces low consumer awareness [3][42]. - Investment opportunities are highlighted in companies with strong technological capabilities and financial strength, particularly those involved in the production of sucralose and erythritol [3][3].

证券代码：002268 证券简称：保龄宝 公告编号：2025-046 保龄宝生物股份有限公司 关于持股5%以上的股东减持股份触及1%刻度的公告 股东宁波趵朴富通资产管理中心(有限合伙)保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 近日，保龄宝生物股份有限公司（以下简称"公司"）收到持股5%以上股东宁 波趵朴富通资产管理中心(有限合伙)（以下简称"趵朴富通"）出具的《关于股份 减持触及1%刻度的告知函》，获悉其在2025年7月3日至2025年8月14日期间通过 集中竞价、大宗交易方式合计减持公司股份4,190,000股，本次变动触及1%刻度。 现将具体情况公告如下： | 信息披露义务人 | 宁波趵朴富通资产管理中心(有限合伙) | | --- | --- | | 住所 | 浙江省宁波市北仑区梅山七星路88号1幢401室A区F0818 | | 权益变动时间 | 2025年7月3日至2025年8月14日 2025年7月3日至2025年8月14日期间，趵朴富通通过 | | | 集中竞价及大宗交易方式合计减持公司股份共计 | | | 4,190,000股，其中集中竞价减持3,570 ...

保龄宝（002286.SZ）8月11日在投资者互动平台表示，目前公司"年产2500吨HMOs（母乳低聚糖）建 设项目"尚在进行投产前的准备工作。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：你好，公司hmos是否已经投产，市场需求度，毛利率 如何？ ...

人民财讯8月7日电，保龄宝（002286）8月7日在互动平台表示，公司HMOs(母乳低聚糖)建设项目设计 产能2500吨，预计2025年下半年投产。 ...

Market Overview - The Shanghai Composite Index is at 3555.41 points, with a decline of 0.50% [1] - The total trading volume of A-shares is 128.87 billion yuan [1] Technical Analysis - A total of 64 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Tongzhou Electronics: -1.29% - Marubi Biological: -0.95% - GeKao Micro: -0.69% [1] Individual Stock Performance - Key stock performances include: - Tongzhou Electronics (002052): Today's change -1.15%, 5-day MA at 10.70 yuan, 10-day MA at 10.84 yuan, with a distance of -1.29% [1] - Marubi Biological (603983): Today's change -2.84%, 5-day MA at 39.78 yuan, 10-day MA at 40.16 yuan, with a distance of -0.95% [1] - GeKao Micro (688728): Today's change 0.33%, 5-day MA at 15.71 yuan, 10-day MA at 15.82 yuan, with a distance of -0.69% [1] - Other notable stocks include: - Huatai Securities (601059): Today's change -0.86%, 5-day MA at 16.73 yuan, 10-day MA at 16.84 yuan, with a distance of -0.66% [1] - Jiabao (600622): Today's change -1.01%, 5-day MA at 3.08 yuan, 10-day MA at 3.10 yuan, with a distance of -0.64% [1] Additional Stock Movements - Other stocks with notable movements include: - Laka Laka (300773): Today's change -4.02%, 5-day MA at 27.62 yuan, 10-day MA at 27.73 yuan, with a distance of -0.39% [2] - Yongtai Technology (002326): Today's change 4.09%, 5-day MA at 13.25 yuan, 10-day MA at 13.29 yuan, with a distance of -0.32% [2] - Qijing (603677): Today's change -0.46%, 5-day MA at 19.91 yuan, 10-day MA at 19.96 yuan, with a distance of -0.25% [2]

1 | 第一章 | | 总则 3 | | --- | --- | --- | | 第二章 | | 经营宗旨和范围 4 | | 第三章 | | 股份 4 | | 第一节 | | 股份发行 4 | | 第二节 | | 股份增减和回购 5 | | 第三节 | | 股份转让 6 | | 第四章 | | 股东和股东会 7 | | 第一节 | | 股东的一般规定 7 | | 第二节 | | 控股股东和实际控制人 10 | | 第三节 | | 股东会的一般规定 11 | | 第四节 | | 股东会的召集 13 | | 第五节 | | 股东会的提案与通知 14 | | 第六节 | | 股东会的召开 15 | | 第七节 | | 股东会的表决和决议 18 | | 第五章 | | 董事和董事会 22 | | 第一节 | | 董事的一般规定 22 | | 第二节 | | 董事会 25 | | 第三节 | | 独立董事 31 | | 第四节 | | 董事会专门委员会 33 | | 第六章 | | 高级管理人员 35 | | 第七章 | | 财务会计制度、利润分配和审计 37 | | 第一节 | | 财务会计制度 37 | | 第二节 ...

2025 年 7 月 28 日，公司已完成上述事项的工商变更登记手续，并取得由德 州市行政审批服务局换发的最新《营业执照》。 换发的最新《营业执照》证载信息如下： 统一社会信用代码：91371400723870085E 名 称：保龄宝生物股份有限公司 类 型：股份有限公司(上市) 股票代码：002286 股票简称：保龄宝 公告编号：2025-045 保龄宝生物股份有限公司 关于完成经营范围工商变更登记的公告 公司董事会及全体成员保证公告内容真实、准确和完整，不存在虚假记录、 误导性陈述或者重大遗漏。 保龄宝生物股份有限公司（以下简称"公司"）分别于 2025 年 6 月 9 日召 开第六届董事会第十一次会议及 2025 年 6 月 26 日召开 2025 年第二次临时股东 会审议通过了《关于变更公司经营范围及修订<公司章程>的议案》。具体内容 详见公司于 2025 年 6 月 10 日在指定信息披露媒体披露的《关于变更公司经营范 围及修订<公司章程>的公告》（公告编号：2025-039）和 2025 年 6 月 27 日披露 的《2025 年第二次临时股东会决议公告》（公告编号：2025-044）。 住 所： ...

Group 1 - A total of 12 stocks received buy ratings from institutions today, with Baolingbao, Puluo Pharmaceutical, and Xinyuanwei being newly covered by institutions [1] - Among the stocks rated, the average increase was 1.14%, outperforming the Shanghai Composite Index, with notable gainers including Xinyuanwei, Shantui, and Hanyi, which rose by 5.56%, 4.41%, and 4.09% respectively [1] - The stocks with the largest declines included Jinbo Biological, Baofeng Energy, and Miao Exhibition, which fell by 2.14%, 1.70%, and 1.60% respectively [1] Group 2 - The newly rated stocks include Puluo Pharmaceutical with a strong buy rating from Huachuang Securities, and Baolingbao with an increase rating from Guotai Haitong [2] - The target price for Puluo Pharmaceutical is set at 22.00 yuan, while Baolingbao has a target price of 16.30 yuan [2] - Other stocks receiving buy ratings include Miaokelan Duo, Tielong Logistics, and Gole Technology, with target prices of 33.00 yuan, 7.09 yuan, and unspecified respectively [2]

Group 1: Company Insights - The company Honghua Digital Science has announced a forecast for its 2025 half-year report, expecting revenue between 1.02 billion to 1.06 billion yuan, representing a year-on-year increase of 25.01% to 29.91% [3] - The net profit attributable to shareholders is projected to be between 240 million to 260 million yuan, reflecting a year-on-year growth of 19.90% to 29.89% [3] - The company benefits from the accelerated transition from traditional printing to digital printing, leading to sustained order growth and expansion of domestic and international customer bases [1][3] Group 2: Industry Trends - The digital printing equipment sector is experiencing rapid growth, with a projected revenue increase of 114.66% year-on-year for 2024, driven by technological advancements and channel expansion [3] - The textile and printing industry is undergoing a transformation, with digital printing becoming essential for responding to fast fashion demands and reducing processing costs [3] - The construction materials industry in Xinjiang is benefiting from geographical advantages, with cement prices maintaining better stability than the national average, supported by the commencement of the China-Kyrgyzstan-Uzbekistan railway [1][14][41] Group 3: Market Strategy - In Q2 2025, active funds increased their stock positions, particularly in the communication, banking, military, and non-bank sectors, while reducing exposure to food and beverage, automotive, and electric sectors [2][6] - The IPO market is showing signs of recovery, with a significant increase in the number of accepted applications and first-day gains remaining above 220% [9][11] - The construction of the China-Kyrgyzstan-Uzbekistan railway is expected to generate a cement demand of approximately 400-600 million tons, benefiting local cement producers [40][41]